S S A R

24th ANNUAL SCANDINAVIAN ATHEROSCLEROSIS CONFERENCE

Programme for the 2018 meeting

 

Download the programme and abstract book

Wednesday, April 11, 2018

16.00 18.00

Arrival, registration and coffee (dining room until 17.45)

 

18.00 19.30

Dinner

 

19.30 19.35

Welcome

Christina Christoffersen (Denmark)

 

 

THE 2017 NIKKILÄ MEMORIAL LECTURE

 

19.35 19.40

Introduction of the 2018 Nikkilä Lecturer

Katariina Öörni (Finland) and Anne Tybjærg-Hansen (Denmark)

 

19.40 20.25

2018 Nikkilä Lecture

Shared risk factors for cardiovascular disease and dementia – epidemiologic, genetic and causal aspects

Ruth Frikke-Schmidt (Denmark)

 

20.25 20.45

Discussion

 

 

20.45 -

Pub will be open

                                            

 

 

Thursday, April 12, 2018

08.00 – 09.00

Breakfast

 

 

Session I. INFLAMMATION AND VASCULAR BIOLOGY

Organized and chaired by Tanja X. Pedersen (Denmark) and Michael Davies (Denmark)

 

09.00 – 09.25

Human macrophages and their proinflammatory responses in atherosclerosis

Petri Kovanen (Finland)

 

09.25 – 09.30

Discussion

 

 

09.30 – 09.45

CETP is produced by resting hepatic macrophages and modulated by lipopoly-saccharide: role of CETP in innate immunity?

Patrick Rensen (The Netherlands)

 

09.45 – 10.00

Engineered regulatory T cell Adoptive Cell Therapy as a novel tool for the treatment of atherosclerosis

Fabrizia Bonacina (Italy)*

 

10.00 – 10.15

Diet-induced dyslipidemia alters the migration of regulatory T cells

Jacob Amersfoort (The Netherlands)*

 

10.15 – 10.30

The Antibody response in Atherosclerosis

Cristina Lorenzo Martín (Spain)* 

10.30 – 11.15

Coffee, poster walks (Session I) and exhibitions

 

 

11.15 – 11.40

Inorganic nitrate and the control of oxygen supply and demand

Andrew Murray (United Kingdom)

 

11.40 – 11.45

Discussion

 

 

11.45 – 12.00

Integrated precision proteomics as an effective way to identify novel pathophysiological mechanisms involved in atherosclerosis

Liam Ward (Sweden)*

 

12.00 – 12.15

Kidney-derived apolipoprotein M does not protect against acute kidney injury.

Line Bisgaard (Denmark)

 

12.15 – 12.30

Autoantibodies to Apolipoprotein A-1 as Independent Predictors of Cardiovascular Mortality in Renal Transplant Recipients

Josephine Anderson (The Netherlands)*

 

 

Session II. CARDIOVASCULAR DISEASE

Organized and chaired by Marianne Benn (Denmark) and Kirsten Holven (Norway)

 

 

12.30 – 12.55

Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol

Reijo Laaksonen (Finland) 

 

12.55 – 13.00

Discussion

 

13.00 – 14.00

Lunch

 

14.00 – 15.00

General meeting of the Scandinavian Society for Atherosclerosis Research
Open for all participants, decision on next year’s topics and chairpersons

 

Afternoon free for the Louisiana Museum of Modern Art (5 min walk), beach (5 min walk),
Kronborg, the castle of Hamlet (12 min by train) or downtown Copenhagen (50 min by train)

 

 

16.30 – 17.30

The traditional soccer match between countries
Remember to bring sports clothing and suitable footwear

 

17.45 – 18.45

Dinner

 

 


Session II. cardiovascular disease – continued

Organized and chaired by Marianne Benn (Denmark) and Kirsten Holven (Norway)

 

 

18.45 – 19.10

Lipoprotein (a) in cardiovascular disease

Børge Nordestgaard (Denmark)

 

19.10 – 19.15

Discussion

 

19.15 – 19.30

High lipoprotein(a) and high risk of cardiovascular and all-cause mortality.

Anne Langsted (Denmark)*

 

19.30 – 19.45

HDL Cholesterol Efflux Capacity is Associated with Incident Cardiovascular Disease in the General Population – a case-control study from PREVEND.

Uwe Tietge (The Netherlands)

 

19.45 – 20.00

Unmet need for primary prevention in individuals with hypertriglyceridemia not eligible for statin therapy according to ESC/EAS guidelines: a contemporary population-based study

Christian Medom Madsen (Denmark)*

 

20.00 – 20.45

Coffee, poster walks (Session II) and exhibitions

 

20.45 – 21.00

Barcoding in obese: who’s at risk for the development of cardiovascular disease?

Margaux Fontaine (The Netherlands)*

 

21.00 – 21.15

Plasma transthyretin and risk of ischemic vascular disease in the general population: a prospective cohort study

Mette Christoffersen (Denmark)

 

21.15 – 21.30

 

LDL cholesterol is more important for some forms of atherosclerotic disease than others. Using the Norwegian cohort of familial hypercholesterolemia as a model disease to generate new understanding of the role of LDL cholesterol.

Kjetil Retterstøl (Norway)

 

21.30-21.45

Using metabolic profiling and gene expression analyses to explore molecular effects of replacing saturated fat with polyunsaturated fat- a randomized controlled dietary intervention study

Kirsten Holven (Norway)

 

 

21.45 –

 

Pub will be open

 


Friday, April 13, 2018

 

08.00 – 09.00

Breakfast.

 

 

 Session III. LIPOPROTEINS AND LIPID TRANSPORT

Organized and chaired by Monique Mulder (The Netherlands) and Katariina Öörnii (Finland)

 

09.00 – 09.25

 

Cellular immunity to LDL in atherosclerosis.

Daniel Ketelhuth (Sweden)

09.25 – 09.30

Discussion

 

09.30 – 09.45

Quercetin lowers plasma triglycerides accompanied by white adipose tissue browning in diet-induced obese mice.

Eline Kuipers (The Netherlands)*

09.45 – 10.00

The ApoM/S1P axis controls triglyceride metabolism and brown fat activity.

Anna Borup (Denmark)*

10.00 – 10.15

A diurnal rhythm in brown adipose tissue causes rapid clearance of plasma lipids at wakening.

Wietse In het Panhuis (The Netherlands)*

10.15 – 10.30

Inhibition of the endocannabinoid system by treatment with a CB1R antagonist improves dyslipidemia.

Robin van Eenige (The Netherlands)*

10.30 – 11.15

Coffee, poster walks (Session III) and exhibitions

 

11.15 – 11.40

The effect of LDL in monocyte-to-macrophage differentiation.

Lina Badimon (Spain)

 

11.40 – 11.45

Discussion

 

11.45 – 12.00

Susceptibility of LDL particles to aggregate is reduced by PCSK9 inhibitor and by healthy diet.

Maija Ruuth (Finland)*

12.00 – 12.15

Low LDL-cholesterol by PCSK9 variation and mortality in 109,800 individuals from the general population.

Marianne Benn (Denmark)

12.15 – 12.30

Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatment

Peter Würtz (Finland)

12.30 – 12.45

Low HDL cholesterol as a “HbA1c” for long-term average elevated triglyceride-rich remnants: three Copenhagen studies including 120,828 individuals and patients.

Børge Nordestgaard (Denmark)

12.45 – 13.45

Lunch

 

 

Session IV. OTHER TOPICS

Organized and chaired by Stefano Romeo (Sweden) and Vesa Olkkonen (Finland)

 

 

13.45 – 14.10

Translational insights into Vascular Growth Factors

Kari Alitalo (Finland)

14.10 – 14.15

Discussion

 

14.15 – 14.30

Intake of added sugars and all-cause and cardiovascular mortality.

Stina Ramne (Sweden)*

 

14.30 – 14.45

Increased glucose and fatty acid metabolism and metabolic flexibility in myotubes from trained subjects.

Nils Gunnar Løvsletten (Norway)*

 

 

 

14.45 – 15.00

OSBP-related protein 2 (ORP2) - a novel regulator of Akt signaling and cellular energy metabolism.

Vesa Olkkonen (Finland)

 

15.00 – 15.15

GPR120 agonism promotes metabolic health by stimulating calcium-dependent mitochondrial respiration in brown fat.

Maaike Schilperoort (The Netherlands)*

 

15.15 – 16.00

Coffee, poster walks (Session IV) and exhibitions

 

16.00 – 16.25

Human genetics of fatty liver disease

Stefano Romeo (Sweden) 

 

16.25 – 16.30

Discussion

 16.30 – 16.45

Very high plasma levels of HDL cholesterol and risk of dementia in the general population.

Emilie Kjeldsen (Denmark)*

 

16.45 – 17.00

Vascular disease, related risk factors and development of dementia – a nationwide study of the Danish population.

Jesper Q. Thomassen (Denmark)

 

17:00 – 17:15

Absolute 10 year risk of dementia by age, gender and APOE genotype for targeted prevention in 104,537 individuals from the general population.

Katrine L. Rasmussen (Denmark)*

 

17.15 – 17.30

 

 

Dietary Sargassum fusiforme improves memory and reduces amyloid plaque load in an Alzheimer's disease mouse model.

Monique Mulder (The Netherlands)

 

17.30 – 19.00

Time free

19.00 – 19.30

Cocktail

 

19.30 –

Banquet and dancing

 

 

Saturday, April 14, 2017

 

08.30 – 10.00         

 

Breakfast

10.00                     

 

 Departure

Have a nice trip back home!!!